Cytosorbents Corp Balance Sheet
CTSO|8 years of annual SEC 10-K data (FY2011-FY2018)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Cytosorbents Corp had $34M in total assets and $17M in shareholders' equity as of FY2018. Total debt was $10M against $22M in cash, resulting in a $12M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.4M | $17.3M | $3.6M | $5.3M | $3.6M | $1.7M | $1.7M | $1.2M |
| Accounts Receivable | $3.9M | $2.2M | $1.4M | $648.9K | $819.2K | $453.0K | $51.8K | $36.1K |
| Inventory | $833.1K | $795.7K | $834.0K | $1.2M | $537.6K | $245.6K | $682.4K | $431.0K |
| Current Assets | $28.3M | $20.7M | $7.8M | $9.9M | $7.6M | $3.5M | $2.9M | $1.7M |
| PP&E (Net) | $1.7M | $1.4M | $569.4K | $557.3K | $245.8K | $144.4K | $145.6K | $155.1K |
| Total Assets | $34.2M | $24.1M | $9.7M | $11.3M | $8.5M | $4.0M | $3.3M | $2.1M |
| Current Liabilities | $6.9M | $7.8M | $6.1M | $3.0M | $4.5M | $3.1M | $2.1M | $1.5M |
| Total Debt | $9.9M | $10.0M | $4.9M | $0 | - | - | - | - |
| Shareholders' Equity | $16.9M | $10.3M | $4.0M | $9.8M | $6.9M | -$11.6M | -$11.6M | -$10.1M |